Eagle Health Investments LP - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 195 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.

Quarter-by-quarter ownership
Eagle Health Investments LP ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$884,918
-21.7%
28,9000.0%0.17%
-34.1%
Q4 2022$1,130,279
-17.9%
28,9000.0%0.26%
-17.4%
Q3 2022$1,377,000
+23.1%
28,9000.0%0.32%
+21.1%
Q2 2022$1,119,000
-32.4%
28,9000.0%0.26%
-36.0%
Q1 2022$1,656,000
-28.1%
28,9000.0%0.41%
-27.3%
Q4 2021$2,303,00028,9000.56%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 2,346,934$74,937,60345.33%
HSG Holding Ltd 796,089$25,419,1222.91%
Deep Track Capital, LP 1,317,316$42,061,9001.95%
Redmile Group, LLC 1,485,199$47,422,4041.82%
ARK Investment Management 8,382,595$267,656,2461.77%
Casdin Capital, LLC 570,000$18,200,1001.59%
Yiheng Capital Management, L.P. 463,800$14,809,1340.80%
Temasek Holdings (Private) Ltd 4,317,789$137,867,0030.80%
Alphabet Inc. 321,604$10,268,8150.55%
FARALLON CAPITAL MANAGEMENT LLC 3,441,522$109,887,7970.55%
View complete list of BEAM THERAPEUTICS INC shareholders